The most important takeaway is not that omega-3s are a proven treatment, but that they may be a useful marker of a broader nutritional pattern linked with better lung outcomes. In observational research, higher blood levels can reflect diet quality, supplement use, overall health status, or lifestyle differences that are hard to separate from one another.
That distinction matters because pulmonary fibrosis is a complex disease with many drivers, and a correlation with omega-3 status does not by itself show that eating more fish or taking supplements will slow scarring. The strongest next step is controlled clinical research that tests whether changing intake actually changes symptoms, lung function decline, or quality of life.
For readers, the practical angle is more measured: omega-3-rich foods can fit into a generally heart-healthy eating pattern, but they are not a substitute for specialist care, oxygen therapy when needed, or approved disease management. In people with chronic illness, supplement choices should also be considered alongside medications, swallowing ability, appetite, and digestive tolerance.
There is also a safety and tailoring issue. โMoreโ is not automatically better, especially when supplements are added without a clear reason. The people most likely to benefit may not be everyone with lung disease, but a subset defined by baseline diet, disease stage, or metabolic differencesโsomething only future studies can clarify.
New research links omega-3 fatty acids found in nuts and fish to improved lung function, which can slow the progression of the often deadly pulmonary fibrosis and prolong the lifespan of patients living with this lung scarring disease without needing an organ transplant. However, researchers call for further investigation.
Pulmonary fibrosis is a life-long condition resulting in the inability of the lungs to exchange oxygen and carbon dioxide, which leads to patients becoming short of breath, weak and unable to exercise, among other symptoms. Smoking is a considerable risk factor.
โSimilar to prior research that has shown higher blood levels of omega-3 fatty acids are associated with better lung function in community-dwelling adults, we also found that higher levels were strongly associated with better lung function over time in humans with pulmonary fibrosis,โ Dr. John Kim, a pulmonary and critical care expert at UVA Health and the School of Medicine, US, tellsย
Nutrition Insight.
โSpecifically, we found patients with higher omega-3 levels had a slower decline in their ability to exchange oxygen and carbon dioxide. Notably, we found higher levels were associated with longer survival.โ
Omega-3โs lung protective role
The research team conducting theย
studyย published in CHEST set out to determine if omega-3 fatty acids could offer protection from interstitial lung disease that can eventually lead to fatal pulmonary fibrosis.
โOur findings extended other research that has shown higher blood levels of omega-3 fatty acids are associated with better lung function and clinical outcomes in other types of lung diseases,โ explains Kim.
The research was conducted by collecting blood samples from more than 300 clinically diagnosed pulmonary fibrosis patients and examining the associations of plasma omega-3 fatty acid levels with changes in the Forced Vital Capacity โ the amount of air that can be forcibly exhaled from a personโs lungs after taking the deepest breath possible โ and capacity for carbon monoxide over a 12-month period.
โOur study was largely correlative, so we donโt exactly know the precise role of omega-3 fatty acids in interstitial lung disease,โ notes Kim.
โNotably, there are published studies from other researchers that have shown the administration of omega-3 fatty acids to be protective in the lungs of mice, and part of this may be due to the metabolites of omega-3 fatty acids.โ
โThereโs a possibility that higher blood levels of omega-3 fatty acids may indicate better health habits that may influence pulmonary fibrosis, and there is, in fact, no direct role of omega-3 fatty acids,โ he adds.
Scientists associate higher levels of omega-3 in the blood with better lung function over time.The need for clinical trials
Kim argues that further research is necessary to improve health outcomes and better understand the role omega-3 plays in lung health.
โTo determine whether omega-3 fatty acids are protective in pulmonary fibrosis, we need clinical trials that test the effect of omega-3 related interventions on pulmonary fibrosis. Importantly, we need studies that determine exactly how omega-3 fatty acids may be protective in humans with pulmonary fibrosis and where in the lung it has its biggest effect.โ
โProspective studies that administer omega-3 fatty acid therapies and dietary-enriched interventions with pre- and post-intervention assessments of the lung are needed to reveal the underlying mechanisms,โ he further outlines. โThere have been several clinical trials with omega-3 fatty acids in other chronic diseases that have been disappointing.โ
โA lot of work needs to be done to determine how these omega-3 fatty acids work in different diseases and whether there are certain individuals who will benefit the most,โ Kim cautions.
Recently, researchersย
discoveredย new biomarkers of the omega-3 index, facilitating cardiovascular and cognitive research by tracing levels in the blood.
Omega-3 fatty acids are
ย linkedย to a wide range of health benefits, from heart health to cognition and immunity support. Innova Market Insights data from late last year suggests an increase in the launch of products that list omega-3 as an ingredient, including sports nutrition and products making claims regarding womenโs and childrenโs health
Related
